• Most people being diagnosed for diabetes were in 60+ age group
• More men found to suffer from diabetes than women

Ahead of World Diabetes Day (14th November), Tata 1mg, India’s leading digital healthcare platform, shared that about 34% of people in Bengaluru who tested for HbA1c at Tata 1mg labs were found to have diabetes, with most of the cases falling in the 40+ age group. The proportion of diabetes patients was found to be higher in men compared to women. This report has been prepared on the basis of a retrospective data analysis conducted on people who wanted to get themselves checked specifically for diabetes, or those who took a preventive health screening package. The screening was done through HbA1c test (or glycosylated hemoglobin test) which tells about the average level of blood sugar over the past 2 to 3 months. A value of HbA1c level ≥ 6.5% is considered to be indicative of diabetes.

A total of 75,661 blood samples were tested for diabetes at Tata 1mg labs in Bengaluru between March-October 2022. Out of these samples, 25,977 (about 34.3%) were diagnosed as positive for the disease. The incidence was 39.3% in the 40-60 years age group, followed by 60+ years (45.2%) and 25-40 years (14.8%). More men (55%) were found to suffer from diabetes compared to women (45%).

Said Dr Prashant Nag, Clinical Head, Tata 1mg Labs: “Diabetes is a leading threat to public health globally, and the view is gloomier for countries like India, where the diabetes burden has risen significantly in recent decades and will continue to rise in the coming decades. As the prevalence of diabetes rises, more young adults and adolescents tend to develop diabetes, particularly if they are overweight/obese. Not just this, more people are now falling prey to borderline diabetes. It is a condition wherein blood sugar levels are slightly above the normal range, but not high enough to be called diabetes. A report published in 2018 estimated 1 in every 6 Indians to have borderline diabetes.”

He added: “All adults in India without risk factors should be screened with a test for prediabetes and type 2 diabetes starting at age 35, instead of age 45. However, many experts have recommended that screening for diabetes should now be initiated at 25 years of age, looking at the recent increase in diabetes cases in young adults in the country.”

In addition to the genetic predisposition, the main culprits for causing surge in diabetes cases in India are unhealthy lifestyle factors like lack of physical activity, excessive fast-food consumption, smoking, and alcohol consumption. However, certain studies have shown that COVID-19 is also capable of causing direct damage to the pancreas that could worsen sugar levels in known diabetics, and even induce the onset of diabetes in previously non-diabetics, the expert said.

Said Ms. Chhavi Kohli, Chief diabetes educator & Nutritionist with Medanta the Medicity, Gurgaon (also on the advisory panel of Tata 1mg): ‘’There is no special diet for Diabetes; the whole idea is to nourish the body by taking various nutrients in the right proportion and right time. The focus should be on eating lots of seasonal colourful vegetables,  consuming healthy fats and adequate protein sources. For carbs, choose a variety of whole grains. Do not miss fruits, use them as snacks and avoid  packaged and processed food items. Also, a lot of myths prevail around the right diet for Diabetes. Do not fall prey to misinformation. Always consult certified nutritionists and diabetes educators for your diabetes.’’

Diabetes imposes lifelong demands on people living with the disease and their families, and people with diabetes do better when they take active control of their own care. Diabetes can be tackled with a balanced and healthy diet, an active lifestyle, timely intake of prescribed medications, regular health checkups, and planned doctor visits.

Samples tested for HbA1c* at Tata 1mg Labs across Bengaluru from March–October 2022:

The current gold standard for diabetes screening is the HbA1c test.

About Tata 1mg 

Tata 1mg is India’s largest Digital Health Platform. The company has scaled up rapidly since 2015 to become India’s #1 Digital Health Company, commanding the leading share of the time spent in the Digital Healthcare category with over 40 million monthly unique users and 500 million monthly page views. 1mg started with a simple vision of making healthcare Affordable, Accessible & Understandable. Tata 1mg operates India’s largest platform comprising e-pharmacy, e-diagnostics, and e-consult services. Tata 1mg is the only company in India operating with a Legit Script & ISO certification for its e-pharmacy lines as well NABL accreditation for its Diagnostics business. In 2021, Tata Digital acquired a majority stake in 1mg, and the company was rebranded as Tata 1mg.

Tata 1mg labs are currently present in Delhi NCR, Mumbai, Pune, Bangalore, Kolkata, Hyderabad, Chennai, Lucknow, Ahmedabad and Dehradun. These state-of-the-art diagnostic labs operated by expert pathologists and microbiologists ensure 100% accurate and fast delivery of reports. The company has a dedicated fleet of trained and fully vaccinated phlebotomists and offers safe home sample collection in more than 40 cities in India.

For more information, please contact PERFECT RELATIONS
Mini @ 99533 09939 / Mini.Sharma@dentsu.com